Apyx Medical (APYX) Short Interest Ratio & Short Volume → Missed NVDA? Buy this AI stock NOW (From Chaikin Analytics) (Ad) Free APYX Stock Alerts $1.58 -0.02 (-1.25%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Apyx Medical Short Interest DataCurrent Short Interest412,600 sharesPrevious Short Interest540,300 sharesChange Vs. Previous Month-23.64%Dollar Volume Sold Short$581,766.00Short Interest Ratio2.8 Days to CoverLast Record DateMay 15, 2024Outstanding Shares34,640,000 sharesFloat Size28,440,000 sharesShort Percent of Float1.45%Today's Trading Volume15,171 sharesAverage Trading Volume130,390 sharesToday's Volume Vs. Average12% Short Selling Apyx Medical ? Sign up to receive the latest short interest report for Apyx Medical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPYX Short Interest Over TimeAPYX Days to Cover Over TimeAPYX Percentage of Float Shorted Over Time Ad Chaikin AnalyticsMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here. Apyx Medical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024412,600 shares $581,766.00 -23.6%1.5%2.8 $1.41 4/30/2024540,300 shares $772,629.00 +45.6%1.9%3.7 $1.43 4/15/2024371,100 shares $512,118.00 -47.5%1.3%2.4 $1.38 3/31/2024706,700 shares $961,112.00 -55.0%2.5%4.4 $1.36 3/15/20241,570,000 shares $2.81 million -1.3%5.2%10.1 $1.79 2/29/20241,590,000 shares $3.34 million +1.3%5.3%15.8 $2.10 Get the Latest News and Ratings for APYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,570,000 shares $3.36 million +4.0%5.2%14 $2.14 1/31/20241,510,000 shares $3.38 million -3.2%5.0%10.6 $2.24 1/15/20241,560,000 shares $3.46 million -1.9%5.2%10.8 $2.22 12/31/20231,590,000 shares $4.17 million -1.9%5.3%10 $2.62 12/15/20231,620,000 shares $3.81 million +1.3%5.4%9.9 $2.35 11/30/20231,600,000 shares $3.78 million -20.8%5.3%9.9 $2.36 11/15/20232,020,000 shares $3.01 million -9.0%6.7%13.7 $1.49 10/31/20232,220,000 shares $5.08 million -7.1%7.4%14.3 $2.29 10/15/20232,390,000 shares $5.63 million -8.1%7.9%12.3 $2.36 9/30/20232,600,000 shares $8.32 million -3.4%8.6%13 $3.20 9/15/20232,690,000 shares $10.52 million -5.6%8.9%10.8 $3.91 8/31/20232,850,000 shares $13.28 million -16.7%9.4%10.6 $4.66 8/15/20233,420,000 shares $16.25 million +39.6%11.3%12 $4.75 7/31/20232,450,000 shares $13.70 million -13.4%8.1%7 $5.59 7/15/20232,830,000 shares $17.09 million +9.7%9.4%9 $6.04 6/30/20232,580,000 shares $12.98 million -27.9%8.5%8.9 $5.03 6/15/20233,580,000 shares $24.88 million -3.5%11.9%14.9 $6.95 5/31/20233,710,000 shares $23.48 million -35.1%12.3%16.7 $6.33 5/15/20235,720,000 shares $32.03 million +17.5%18.9%23.5 $5.60 4/30/20234,870,000 shares $16.56 million +3.4%16.1%34.7 $3.40 4/15/20234,710,000 shares $14.13 million +12.7%15.6%27.7 $3.00 3/31/20234,180,000 shares $12.04 million +1.7%13.8%21.2 $2.88 3/15/20234,110,000 shares $10.77 million +25.7%13.6%19.2 $2.62 2/28/20233,270,000 shares $10.63 million +2.5%10.8%14.7 $3.25 2/15/20233,190,000 shares $10.53 million +4.6%10.6%13.2 $3.30 1/31/20233,050,000 shares $8.91 million +146.0%10.1%8 $2.92 1/15/20231,240,000 shares $3.21 million +42.5%4.1%3.5 $2.59 12/30/2022870,400 shares $2.04 million -5.0%2.9%2.7 $2.34 12/15/2022916,400 shares $1.76 million -3.0%3.0%3 $1.92 11/30/2022944,700 shares $1.66 million -21.9%3.1%3.2 $1.76 11/15/20221,210,000 shares $2.11 million +42.6%4.0%4.1 $1.74 10/31/2022848,800 shares $4.24 million +10.4%2.8%6.5 $5.00 10/15/2022768,600 shares $3.15 million +8.2%2.6%6 $4.10 9/30/2022710,600 shares $3.19 million +49.8%2.4%5 $4.49Missed NVDA? Buy this AI stock NOW (Ad)After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here. 9/15/2022474,300 shares $2.91 million -3.1%1.6%2.1 $6.14 8/31/2022489,200 shares $2.80 million -19.3%1.6%1.9 $5.73 8/15/2022606,100 shares $4.53 million -28.1%2.0%0.8 $7.47 7/31/2022842,500 shares $7.97 million +25.3%2.8%1.1 $9.46 7/15/2022672,600 shares $5.04 million -13.2%2.2%0.9 $7.50 6/30/2022775,000 shares $4.54 million -58.8%2.7%1 $5.86 6/15/20221,880,000 shares $11.37 million -33.1%6.5%2.5 $6.05 5/31/20222,810,000 shares $17.06 million +138.1%9.3%4.1 $6.07 5/15/20221,180,000 shares $4.31 million +21.8%3.9%7.9 $3.65 4/30/2022968,500 shares $3.65 million +25.6%3.2%7.4 $3.77 4/15/2022771,100 shares $4.13 million +40.6%2.6%6.9 $5.35 3/31/2022548,600 shares $3.58 million +12.4%1.8%5.4 $6.53 3/15/2022488,300 shares $2.87 million +11.1%1.6%5.6 $5.87 2/28/2022439,500 shares $4.45 million +7.9%1.5%7.8 $10.12 2/15/2022407,300 shares $4.29 million +18.0%1.4%6.3 $10.53 1/31/2022345,200 shares $3.97 million -10.6%1.2%4.6 $11.50 1/15/2022386,000 shares $4.49 million +11.7%1.3%5.1 $11.63 12/31/2021345,600 shares $4.43 million -2.4%1.2%4.8 $12.82 12/15/2021354,100 shares $4.49 million -5.9%1.2%3.5 $12.69 11/30/2021376,100 shares $5.05 million -7.6%1.3%3.8 $13.43 11/15/2021407,000 shares $6.63 million -14.3%1.4%4.2 $16.30 10/29/2021475,000 shares $6.79 million -5.9%1.6%5.3 $14.30 10/15/2021504,500 shares $6.63 million -6.9%1.7%5.9 $13.15 9/30/2021542,100 shares $7.51 million +10.0%1.8%6.4 $13.85 9/15/2021492,800 shares $5.48 million +2.9%1.6%6.5 $11.11 8/31/2021478,900 shares $5.66 million +5.0%1.6%6.1 $11.81 8/13/2021456,300 shares $4.98 million +0.9%1.5%5.8 $10.91 7/30/2021452,100 shares $4.07 million -0.8%1.5%5.7 $9.00 7/15/2021455,900 shares $4.17 million -0.6%1.5%5.5 $9.14 6/30/2021458,500 shares $4.73 million -15.7%1.5%5 $10.31 6/15/2021544,100 shares $5.52 million -4.6%1.8%7.2 $10.15 5/28/2021570,400 shares $5.58 million +2.6%1.9%7.3 $9.79 5/14/2021555,800 shares $5.39 million +9.2%1.9%6.4 $9.70 4/30/2021508,900 shares $5.16 million -5.3%1.7%6.1 $10.14 4/15/2021537,200 shares $5.07 million -7.7%1.8%5.9 $9.44 3/31/2021581,800 shares $5.75 million -6.1%1.9%6.1 $9.88 3/15/2021619,300 shares $7.12 million -0.7%2.1%7 $11.49 2/26/2021623,700 shares $6.56 million +10.3%2.1%7.4 $10.51 2/12/2021565,500 shares $5.79 million +4.3%1.9%6.7 $10.24 1/29/2021542,000 shares $5.13 million +4.3%1.8%6.5 $9.47 1/15/2021519,900 shares $4.81 million -1.4%1.7%6.6 $9.26 12/31/2020527,000 shares $3.94 million +1.9%1.8%8.9 $7.48 12/15/2020517,200 shares $3.59 million +0.5%1.7%9.1 $6.94 11/30/2020514,700 shares $3.98 million +0.9%1.7%9.2 $7.73 11/15/2020510,100 shares $3.42 million -0.4%1.7%8.9 $6.71 10/30/2020512,100 shares $3.00 million -3.9%1.7%8.9 $5.86 10/15/2020532,700 shares $2.95 million +1.2%1.8%8.5 $5.53 9/30/2020526,600 shares $2.48 million +2.4%1.8%7.9 $4.71 9/15/2020514,100 shares $2.58 million -0.2%1.7%6.1 $5.01 8/31/2020515,300 shares $2.37 million -13.9%1.7%4.6 $4.59Missed NVDA? Buy this AI stock NOW (Ad)After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here. 8/14/2020598,600 shares $3.03 million -10.4%2.0%5.1 $5.07 7/31/2020668,000 shares $3.00 million +10.7%2.2%5.1 $4.49 7/15/2020603,700 shares $2.97 million +6.4%2.0%4.6 $4.92 6/30/2020567,300 shares $3.15 million +43.6%1.9%4.2 $5.55 6/15/2020395,200 shares $1.92 million -11.0%1.3%3 $4.87 5/29/2020443,800 shares $1.97 million +24.2%1.5%3.7 $4.44 5/15/2020357,400 shares $1.29 million -3.1%1.2%3 $3.61 4/30/2020368,900 shares $1.38 million -22.7%1.3%3.6 $3.73 4/15/2020477,400 shares $1.67 million -9.5%1.6%5.1 $3.49 3/31/2020527,200 shares $1.78 million -44.9%1.8%5.6 $3.37 3/13/2020957,200 shares $3.80 million -5.2%3.2%11.1 $3.97 2/28/20201,010,000 shares $3.27 million -1.0%3.4%14.6 $3.24 2/14/20201,020,000 shares $5.64 million -20.3%3.4%14.5 $5.53 1/31/20201,280,000 shares $8.91 million -0.8%4.3%14.4 $6.96 1/15/20201,290,000 shares $10.35 million +5.7%4.3%13.5 $8.02 12/31/20191,220,000 shares $9.77 million No Change4.1%12.3 $8.01 8/15/20191,151,000 shares $8.02 million -11.3%4.0%6.4 $6.97 APYX Short Interest - Frequently Asked Questions What is Apyx Medical's current short interest? Short interest is the volume of Apyx Medical shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 412,600 shares of APYX short. 1.45% of Apyx Medical's shares are currently sold short. Learn More on Apyx Medical's current short interest. What is a good short interest ratio for Apyx Medical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APYX shares currently have a short interest ratio of 3.0. Learn More on Apyx Medical's short interest ratio. Which institutional investors are shorting Apyx Medical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Apyx Medical: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Apyx Medical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.45% of Apyx Medical's floating shares are currently sold short. Is Apyx Medical's short interest increasing or decreasing? Apyx Medical saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 412,600 shares, a drop of 23.6% from the previous total of 540,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Apyx Medical's float size? Apyx Medical currently has issued a total of 34,640,000 shares. Some of Apyx Medical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apyx Medical currently has a public float of 28,440,000 shares. How does Apyx Medical's short interest compare to its competitors? 1.45% of Apyx Medical's shares are currently sold short. Here is how the short interest of companies compare to Apyx Medical: DarioHealth Corp. (4.91%), SEP Acquisition Corp. (0.45%), Cytosorbents Co. (2.69%), IceCure Medical Ltd (1.21%), Lucid Diagnostics Inc. (2.03%), Monogram Orthopaedics, Inc. (1.95%), GlucoTrack, Inc. (0.04%), Beyond Air, Inc. (10.49%), Carmell Co. (0.23%), Daxor Co. (0.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Apyx Medical stock? Short selling APYX is an investing strategy that aims to generate trading profit from Apyx Medical as its price is falling. APYX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Apyx Medical? A short squeeze for Apyx Medical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APYX, which in turn drives the price of the stock up even further. How often is Apyx Medical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APYX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: DarioHealth Short Squeeze SEP Acquisition Short Squeeze Cytosorbents Short Squeeze IceCure Medical Short Squeeze Lucid Diagnostics Short Squeeze Monogram Orthopaedics Short Squeeze GlucoTrack Short Squeeze Beyond Air Short Squeeze Carmell Short Squeeze Daxor Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APYX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.